<code id='2F1724FB11'></code><style id='2F1724FB11'></style>

<acronym id='2F1724FB11'></acronym>

<center id='2F1724FB11'><center id='2F1724FB11'><tfoot id='2F1724FB11'></tfoot></center><abbr id='2F1724FB11'><dir id='2F1724FB11'><tfoot id='2F1724FB11'></tfoot><noframes id='2F1724FB11'>

<optgroup id='2F1724FB11'><strike id='2F1724FB11'><sup id='2F1724FB11'></sup></strike><code id='2F1724FB11'></code></optgroup>

<b id='2F1724FB11'><label id='2F1724FB11'><select id='2F1724FB11'><dt id='2F1724FB11'><span id='2F1724FB11'></span></dt></select></label></b><u id='2F1724FB11'></u>

~~<i id='2F1724FB11'><strike id='2F1724FB11'><tt id='2F1724FB11'><pre id='2F1724FB11'></pre></tt></strike></i>~~

Home» knowledge» Wikipedia

Wikipedia

Wikipedia

author：entertainment 2025-10-06 06:18:39 Page View：81

Adobe

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

advertisement

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

comprehensive

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Cytokinetics CEO stresses company can launch heart drug on its own

Cytokinetics CEO stresses company can launch heart drug on its own

CytokineticsCEORobertBlumspokeThursdayatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

Malaria cases in Florida and Texas: Here’s what you need to know

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Eli Lilly to pay $200M for Beam’s stake in gene

AdobeEliLillysaidTuesdaythatitwillpay$200milliontogene-editingfirmBeamTherapeuticsforBeam’sstakeinVe

read more